1. Intraperitoneal aerosolization of albumin-bound paclitaxel nanoparticles (Abraxane®) for peritoneal metastasis: a phase I first-in-human study. Issue 2 (February 2021) Authors: Van de Sande, Leen; Graversen, M.; Vermeulen, A.; Reynders, D.; Goetghebeur, E.; Cosyns, S.; Willaert, W.; Ceelen, W. Journal: European journal of surgical oncology Issue: Volume 47:Issue 2(2021) Page Start: e29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OC-0370: Surveillance or metastasis-directed Therapy for OligoMetastatic Prostate cancer (STOMP). (November 2020) Authors: Ost, P.; Reynders, D.; Decaestecker, K.; Fonteyne, V.; Lumen, N.; De Bruycker, A.; Lambert, B.; Delrue, L.; Bultijnck, R.; Goetghebeur, E.; Villeirs, G.; De Man, K.; Ameye, F.; Billiet, I.; Joniau, S.; Vanhaverbeke, F. Journal: Radiotherapy and oncology Issue: Volume 152(2020)Supplement 1 Page Start: S200 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OC-0603 PEACE V – STORM randomized phase II trial for oligorecurrent nodal prostate cancer: acute toxicity. (May 2022) Authors: Zilli, T.; Siva, S.; Heikkilä, R.; Dirix, P.; Liefhooghe, N.; Otte, F.; Gomez-Iturriaga, A.; Everaerts, W.; Shelan, M.; Conde- Moreno, A.; López Campos, F.; Papachristofilou, A.; Guckenberger, M.; Scorsetti, M.; Zapatero, A.; Villafranca Iturre, A.; Eito, C.; Couñago, F.; Muto, P.; Van De Voorde, L. Journal: Radiotherapy and oncology Issue: Volume 170(2022)Supplement 1 Page Start: S528 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OC-0625 Immuno-radiotherapy in solid tumors: preliminary results of the randomized phase 2 CHEERS trial. (August 2021) Authors: Spaas, M.; Sundahl, N.; Rottey, S.; Kruse, V.; De Maeseneer, D.; Duprez, F.; Dirix, P.; Surmont, V.; Lievens, Y.; Van den Begin, R.; Van Gestel, D.; Renard, V.; Reynders, D.; Goetghebeur, E.; Ost, P. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S490 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OC-0682: Phase 1 trial of pembrolizumab with SBRT in metastatic urothelial carcinoma. (April 2018) Authors: Sundahl, N.; Rottey, S.; Decaestecker, K.; De visschere, P.; De maeseneer, D.; Reynders, D.; Meireson, A.; Goetghebeur, E.; Fonteyne, V.; Verbeke, S.; Brochez, L.; Ost, P. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S357 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PO-1378 Metastasis-directed therapy for oligorecurrent prostate cancer: a pooled analysis. (August 2021) Authors: Ost, P.; Berlin, A.; Siva, S.; Reynders, D.; Phillips, R.; Glicksman, R.; Faroudi, F.; Fonteyne, V.; Deek, M.; Chung, P.; Murphy, D.; Tran, P. Journal: Radiotherapy and oncology Issue: Volume 161(2021)supplement Page Start: S1128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. SP-0375: Surveillance or metastasis-directed Therapy for OligoMetastatic Prostate cancer recurrence. (April 2018) Authors: Ost, P.; Reynders, D.; Decaestecker, K.; Fonteyne, V.; Lumen, N.; De Bruycker, A.; Lambert, B.; Delrue, L.; Bultijnck, R.; Goetghebeur, E.; De Man, K.; De Meerleer, G. Journal: Radiotherapy and oncology Issue: Volume 127(2018)Supplement 1 Page Start: S191 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗